|Event Name||CHI 2013 The Evidence Based Reimbursement Summit
Monday, October 21, 2013
Wednesday, October 23, 2013
Hyatt Regency Bethesda
|Description||Part 1: Generating Evidence for Reimbursement Decisions: Therapeutics
It is important to formulate goals for generating, collecting, and analyzing reimbursement evidence early in product development in order to ensure commercial success of a drug or a biologic. We are witnessing the emergence of a new integrated strategy while the biopharmaceutical industry is partnering up with payers to develop evidence of a product's validity and utility, as well as comparative clinical and cost effectiveness. The second annual Generating Evidence for Reimbursement Decisions: Therapeutics conference is designed to bring together all major stakeholders in the field of evidence-based reimbursement such as clinical development experts, reimbursement and government affairs specialists, health care economists and payers. The conference will be directly followed by the second annual Generating Evidence for Reimbursement Decisions: Diagnostics conference, with a shared session on Evidence-Based Reimbursement in Personalized Medicine/Companion Diagnostics bringing the two audiences together.
Part 2: Generating Evidence for Reimbursement Decisions: Diagnostics
Achieving commercial success for an IVD product or a device is becoming progressively more difficult in the current healthcare environment. The combination of tightening a health care budget and the launch of a large number of expensive molecular tests creates complications for payers to respond in traditional ways. Recent changes to the CPT coding system complicate the situation even more. Comprehensive clinical data demonstrating clinical utility and medical value have increasingly become the condition of getting a test reimbursed. The second annual Generating Evidence for Reimbursement Decisions: Diagnostics conference is designed to bring together major players in the field of evidence-based reimbursement in diagnostics.
|Host Company||Cambridge Healthtech Institute